These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 18394869

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. PCA-CR analysis of dissolution profiles. A chemometric approach to probe the polymorphic form of the active pharmaceutical ingredient in a drug product.
    Maggio RM, Castellano PM, Kaufman TS.
    Int J Pharm; 2009 Aug 13; 378(1-2):187-93. PubMed ID: 19477254
    [Abstract] [Full Text] [Related]

  • 3. Mathematical evaluation of similarity factor using various weighing approaches on aceclofenac marketed formulations by model-independent method.
    Soni TG, Desai JU, Nagda CD, Gandhi TR, Chotai NP.
    Pharmazie; 2008 Jan 13; 63(1):31-4. PubMed ID: 18271300
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative dissolution rate studies of commercial furosemide tablets.
    Gadalla MA, Ismail AA.
    Pharmazie; 1981 Aug 13; 36(8):553-6. PubMed ID: 7291288
    [Abstract] [Full Text] [Related]

  • 6. Statistical assessment of dissolution and drug release profile similarity using a model-dependent approach.
    Berry MR, Likar MD.
    J Pharm Biomed Anal; 2007 Oct 18; 45(2):194-200. PubMed ID: 17640841
    [Abstract] [Full Text] [Related]

  • 7. Assessment of similarity between dissolution profiles.
    Ma MC, Wang BB, Liu JP, Tsong Y.
    J Biopharm Stat; 2000 May 18; 10(2):229-49. PubMed ID: 10803727
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of marketed and formulated furosemide tablets.
    Elgindy NA, Ismail AA, Gadalla MA.
    Pharmazie; 1981 Sep 18; 36(9):628-30. PubMed ID: 7301904
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Physical properties and dissolution profiles of acetaminophen and acetylsalicyclic acid tablets made from sucrose-based vehicles.
    Elsabbagh HM, Ghanem AH, Elshaboury MH.
    Pharmazie; 1981 Sep 18; 36(7):488-92. PubMed ID: 7280001
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Applications of NIR in early stage formulation development. Part II. Content uniformity evaluation of low dose tablets by principal component analysis.
    Li W, Bagnol L, Berman M, Chiarella RA, Gerber M.
    Int J Pharm; 2009 Oct 01; 380(1-2):49-54. PubMed ID: 19576977
    [Abstract] [Full Text] [Related]

  • 15. Correlation between in vitro and in vivo parameters of commercial paracetamol tablets.
    Babalola CP, Oladimeji FA, Femi-Oyewo MN.
    Afr J Med Med Sci; 2001 Dec 01; 30(4):275-80. PubMed ID: 14510103
    [Abstract] [Full Text] [Related]

  • 16. Multiple-time-point dissolution specifications for a sampling acceptance plan.
    Chen JJ, Tsong Y.
    J Biopharm Stat; 1997 May 01; 7(2):259-70. PubMed ID: 9136068
    [Abstract] [Full Text] [Related]

  • 17. In vitro bioequivalence study of nine brands of artesunate tablets marketed in Nigeria.
    Esimone CO, Okoye FB, Onah BU, Nworu CS, Omeje EO.
    J Vector Borne Dis; 2008 Mar 01; 45(1):60-5. PubMed ID: 18399319
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Dissolution Similarity Assessment Methods for Products with Large Variations: f2 Statistics and Model-Independent Multivariate Confidence Region Procedure for Dissolution Profiles of Multiple Oral Products.
    Yoshida H, Shibata H, Izutsu KI, Goda Y.
    Biol Pharm Bull; 2017 Mar 01; 40(5):722-725. PubMed ID: 28458360
    [Abstract] [Full Text] [Related]

  • 19. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
    Garbacz G, Wedemeyer RS, Nagel S, Giessmann T, Mönnikes H, Wilson CG, Siegmund W, Weitschies W.
    Eur J Pharm Biopharm; 2008 Oct 01; 70(2):421-8. PubMed ID: 18582568
    [Abstract] [Full Text] [Related]

  • 20. In vitro Comparative Quality Assessment of Different Brands of Furosemide Tablets Marketed in Northwest Ethiopia.
    Abebe S, Ketema G, Kassahun H.
    Drug Des Devel Ther; 2020 Oct 01; 14():5119-5128. PubMed ID: 33262573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.